NurExone Biologic Inc. (J90.F)
Develops exosome therapies to treat spinal cord and brain injuries
0.26+0.01%Healthcare
StockGlow Score
Bearish
BearishBullish
1 year ago-43.1%
The outlook
J90.F trades at the absolute bottom of its 52-week range, sitting well below both its 50- and 200-day moving averages. Analyst coverage appears limited, and the overall sentiment registers as bearish. The stock showed minimal movement today.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range0% of the way from its 52-week low to high
Market cap
$24.3M
52-wk high
0.70
52-wk low
0.26
50-day avg
0.33
200-day avg
0.38
Trailing P/E
—